Résultats de recherche
30 juin 2024 · ICON is the world's leading clinical research organisation, providing outsourced clincal development and commercialisation services to the pharmaceutical, biotechnology and medical device industries.
22 juin 2024 · ICON is the world’s leading clinical research organisation, powered by healthcare intelligence. ICON applies innovation to drive emerging therapies forward and improve patient’s lives.
2 juil. 2024 · Instead of channelling all site-level safety efforts into efficient responses, ICON has taken a proactive approach to identifying risks to patient safety, resulting in the implementation of the Modified Early Warning Score (MEWS) in our research and screening centres.
Il y a 5 jours · Near real-time sync with published outcomes research; Gather intelligence on outcomes trends and effectiveness; Build new commercial opportunities in healthcare intelligence beyond clinical research
Il y a 3 jours · We offer the highest quality services for pharmacokinetic, immunogenicity, biomarker, and CMC analysis, utilising a wide range of platforms for small molecules, large molecules, and cell-based entities.
Il y a 3 jours · ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical ...
1 juil. 2024 · ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the second quarter 2024...
